BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 24, 2015
View Archived Issues
Phase Ib trial set to evaluate tolerogenic dendritic cells for MS and neuromyelitis optica
Read More
Encouraging results on S-44858 for the treatment of CNS diseases
Read More
Inotek Pharmaceuticals provides update on development strategy for trabodenoson
Read More
Chugai updates pipeline progress of second quarter 2015
Read More
DiffronC Technology targeting NR2F6 shows potential for the treatment of leukemia
Read More
PharmaMar forms license agreement with TTY Biopharm for Aplidin
Read More
CEA-Leti and Diabeloop to develop artificial pancreas to improve diabetes treatment
Read More
Novel GSM shows promise for the treatment of AD
Read More
Brincidofovir reduces mortality in animal model of smallpox
Read More
Cara Therapeutics reports data from phase II trial in uremic pruritus
Read More
Norgine patents CCR9 antagonists
Read More
Purdue Pharma discloses opioid receptor agonists
Read More
Merck & Co. develops ROMK channel blockers
Read More
Polyphor divulges selective elastase inhibitors
Read More
Lifesci Pharmaceuticals reports KLKB1 inhibitors
Read More
Model created to investigate the role of butyrylcholinesterase in Alzheimer's disease
Read More
Bristol-Myers Squibb describes IRAK-4 inhibitors
Read More
EMA accepts for review MAA for grazoprevir/elbasvir in HCV
Read More
Sunesis updates regulatory progress for vosaroxin in AML
Read More
EMA committee adopts positive scientific opinion for Mosquirix
Read More
Inovio and EORTC to conduct phase II trial of INO-3112 in cervical cancer
Read More
Janssen files sNDA for reduced-duration treatment with simeprevir in HCV infection
Read More
New preclinical study investigates PharmaCyte's treatment in ascites
Read More
Baxalta acquires asparaginase portfolio from Sigma-Tau
Read More
Amgen submits sNDA for Kyprolis in relapsed multiple myeloma
Read More
AstraZeneca forms partnership with inhaler monitoring company Adherium
Read More